These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10064642)

  • 1. Symptoms as an index of biologic behavior in head and neck cancer.
    Pugliano FA; Piccirillo JF; Zequeira MR; Fredrickson JM; Perez CA; Simpson JR
    Otolaryngol Head Neck Surg; 1999 Mar; 120(3):380-6. PubMed ID: 10064642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical-severity staging system for oral cavity cancer: five-year survival rates.
    Pugliano FA; Piccirillo JF; Zequeira MR; Fredrickson JM; Perez CA; Simpson JR
    Otolaryngol Head Neck Surg; 1999 Jan; 120(1):38-45. PubMed ID: 9914547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of comorbidity in head and neck cancer.
    Piccirillo JF
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients.
    Peter F; Wittekindt C; Finkensieper M; Kiehntopf M; Guntinas-Lichius O
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):171-8. PubMed ID: 23007690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrition impact symptoms in a population cohort of head and neck cancer patients: multivariate regression analysis of symptoms on oral intake, weight loss and survival.
    Farhangfar A; Makarewicz M; Ghosh S; Jha N; Scrimger R; Gramlich L; Baracos V
    Oral Oncol; 2014 Sep; 50(9):877-83. PubMed ID: 25017804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical-severity staging system for oropharyngeal cancer: five-year survival rates.
    Pugliano FA; Piccirillo JF; Zequeira MR; Emami B; Perez CA; Simpson JR; Fredrickson JM
    Arch Otolaryngol Head Neck Surg; 1997 Oct; 123(10):1118-24. PubMed ID: 9339990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of symptoms and comorbidity on prognosis in stage IB cervical cancer.
    Peipert JF; Wells CK; Schwartz PE; Feinstein AR
    Am J Obstet Gynecol; 1993 Sep; 169(3):598-604. PubMed ID: 8372869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
    Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion of comorbidity in a staging system for head and neck cancer.
    Piccirillo JF
    Oncology (Williston Park); 1995 Sep; 9(9):831-6; discussion 841, 845-8. PubMed ID: 8562325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
    Smith VA; MaDan OP; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft-tissue sarcomas of the head and neck: a retrospective analysis of the Alberta experience 1974 to 1999.
    Huber GF; Matthews TW; Dort JC
    Laryngoscope; 2006 May; 116(5):780-5. PubMed ID: 16652087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
    Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
    Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas.
    Nguyen TV; Yueh B
    Cancer; 2002 Aug; 95(3):553-62. PubMed ID: 12209747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Zimmermann F; Betz M; Bodis S; Bernier J; Studer G; Aebersold DM;
    Radiother Oncol; 2012 Aug; 104(2):213-8. PubMed ID: 22726581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer.
    de Cássia Braga Ribeiro K; Kowalski LP; Latorre Mdo R
    Arch Otolaryngol Head Neck Surg; 2003 Feb; 129(2):219-28. PubMed ID: 12578453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
    Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for postoperative complications in oral cancer and their prognostic implications.
    de Melo GM; Ribeiro KC; Kowalski LP; Deheinzelin D
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):828-33. PubMed ID: 11448358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
    Castro MA; Dedivitis RA; Ribeiro KC
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.